Moxifloxacin-containing triple therapy after non-bismuth quadruple therapy failure for Helicobacter pylori infection

Table 1 Demographic characteristics of the study population n (%)

	1-wk MCT	2-wk MCT
No. of patients	60	38
Age (mean ± SD), yr	55.5 ± 9.9	59.4 ± 11.7
Sex (male/female), n	28/32	23/15
Comorbidity
Hypertension	10 (16.7)	11 (28.9)
Diabetes	2 (3.3)	5 (13.2)
Current smoking	4 (6.7)	4 (10.5)
Alcohol intake	10 (16.7)	7 (18.4)
Endoscopic diagnosis
HPAG	51 (85.0)	29 (76.3)
GU	1 (1.7)	2 (5.3)
DU	7 (11.7)	5 (13.2)
GU + DU	1 (1.7)	2 (5.3)

MCT: Moxifloxacin-containing triple therapy; HPAG: Helicobacter pylori-associated gastritis; GU: Gastric ulcer; DU: Duodenal ulcer.